Recent news on Extendryl

Auriga Laboratories Appoints Elliot M. Maza To Its Board of Directors  -  May 9, 2007
PharmaLive.com (press release),...and the Zinx(TM), Extendryl(R), and Levall(R) families of products for relief of symptoms associated with a range of acute respiratory diseases.

Auriga Laboratories Expects Q1 2007 Gross Revenue to Exceed a ...  -  Apr 2, 2007
Genetic Engineering News (press release),...and the Zinx(TM), Extendryl(R), and Levall(R) families of products for relief of symptoms associated with a range of acute respiratory diseases.

Auriga Laboratories Expects Q1 2007 Gross Revenue to Exceed a ...  -  Apr 2, 2007
Business Wire (press release),...and the Zinx™, Extendryl®, and Levall® families of products for relief of symptoms associated with a range of acute respiratory diseases.

Auriga Laboratories Launches Zinx Cold Remedy Products  -  Mar 7, 2007
PharmaLive.com (press release),..."The addition of Zinx to our respiratory franchises, Extendryl(R) and Levall(R), expands the options for doctors looking for treatment alternatives for

Auriga Laboratories Launches Zinx™ Cold Remedy Products  -  Mar 7, 2007
Business Wire (press release),...“The addition of Zinx to our respiratory franchises, Extendryl ® and Levall ® , expands the options for doctors looking for treatment alternatives for their

Auriga Laboratories Sales Force Doubles Again to 200 Associates ...  -  Mar 19, 2007
PharmaLive.com (press release),...and the Zinx(TM), Extendryl(R), and Levall(R) families of products for relief of symptoms associated with a range of acute respiratory diseases.

Auriga Laboratories Sales Force Doubles Again to 200 Associates ...  -  Mar 19, 2007
Business Wire (press release),...and the Zinx™, Extendryl®, and Levall® families of products for relief of symptoms associated with a range of acute respiratory diseases.

Auriga Labs Reports Record Monthly Filled Prescriptions Totaling 26004  -  Feb 20, 2007
Genetic Engineering News (press release),...and the Zinx(TM), Extendryl(R), and Levall(R) families of products for relief of symptoms associated with a range of acute respiratory diseases.

Auriga Labs Reports Preliminary Year-End 2006 Gross Revenues and ...  -  Feb 5, 2007
Business Wire (press release),Auriga recently reported that independent monthly IMS data shows Auriga’s total dispensed prescriptions for its Extendryl family of products increased 146%

Trevor K. Pokorney Joins Auriga Laboratories Board of Directors  -  Feb 12, 2007
Business Wire (press release),...and the Zinx™, Extendryl®, and Levall® families of products for relief of symptoms associated with a range of acute respiratory diseases.

Auriga Laboratories Sales Force Doubles to 100 Associates Since ...  -  18 Jan 2007
PharmaLive.com (press release),Independent monthly IMS data shows Auriga's total dispensed prescriptions for its Extendryl family of products increased 146% in December 2006,

Auriga Laboratories Appoints Jae Yu As Vice President of Finance  -  Jan 8, 2007
PharmaLive.com (press release),Auriga's exclusive product portfolio currently includes the Extendryl(R) and Levall(R) families of prescription products, indicated for relief of symptoms

Auriga Laboratories Appoints Jae Yu As Vice President of Finance  -  Jan 8, 2007
Business Wire (press release),Auriga's exclusive product portfolio currently includes the Extendryl® and Levall® families of prescription products, indicated for relief of symptoms

Auriga Laboratories Increases Pharmaceutical Sales Representatives  -  Dec 14, 2006
PharmaLive.com (press release),The sales force distributes the Company's rapidly-growing innovative line of pharmaceutical products including the Extendryl(R) line of cough and cold

Auriga Laboratories Acquires Exclusive Rights to Patent-Protected ...  -  Dec 6, 2006
Genetic Engineering News (press release),...via ColdCure along with our respiratory franchises, Extendryl(R) and Levall(R), means turnkey treatment to our patients suffering from cold symptoms.

Auriga Laboratories Acquires Exclusive Rights to Patent-Protected ...  -  Dec 6, 2006
Business Wire (press release),...colds via ColdCure along with our respiratory franchises, Extendryl® and Levall®, means turnkey treatment to our patients suffering from cold symptoms.

Auriga Laboratories Enters Into Trade Development Agreement with ...  -  Dec 1, 2006
Genetic Engineering News (press release),...relationships with all classes of trade, giving Auriga significant opportunity to expand distribution of our Extendryl(R) and Levall(R) product lines.

Auriga Laboratories Enters Into Trade Development Agreement with ...  -  Dec 1, 2006
Business Wire (press release),...relationships with all classes of trade, giving Auriga significant opportunity to expand distribution of our Extendryl® and Levall® product lines.

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional